Prediction of the Mechanism of Shaoyao Gancao Decoction in the Treatment of Alopecia Areata by Network Pharmacology and Its Preliminary Verification Study
- PMID: 35432570
- PMCID: PMC9010174
- DOI: 10.1155/2022/5764107
Prediction of the Mechanism of Shaoyao Gancao Decoction in the Treatment of Alopecia Areata by Network Pharmacology and Its Preliminary Verification Study
Abstract
Objective: To explore the mechanism of Shaoyao Gancao decoction (SGD) in treatment of alopecia areata (AA) by network pharmacology and animal experiments.
Methods: Based on the traditional Chinese medicine systems pharmacology database and analysis platform (TCMSP), the components and targets of SGD were determined. Then, the related targets of AA were retrieved from DrugBank, GeneCards, OMIM, and DisGeNET databases. The intersection of drug targets and disease targets was determined, and the key targets of the protein-protein interaction network were obtained with the String database. Gene Ontology (GO) biological process enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of potential key targets were carried out using the DAVID database using AutoDock for molecular docking verification. Finally, the key pathway was validated by animal experiments.
Results: A total of 102 active components, 212 predicted targets, and 812 AA disease-related targets were obtained. Topological analysis yielded 45 key targets of SGD in the treatment of AA, including IL-6, PTGS2, TNF, VEGFA, CCL2, IL-1B, CXCL8, CASP3, MPO, and IL-10. There were 324 GO entries obtained through GO biological process enrichment analysis, and 20 pathways were obtained through KEGG pathway enrichment analysis, involving the PI3K-Akt signaling pathway, osteoclast differentiation, and Jak-STAT signaling pathway. The molecular docking results showed effective ingredients (quercetin, kaempferol, and 7-methoxy-2-methyl isoflavone) have good docking results with targets (IL-6, PTGS2, and TNF). The results of animal experiments showed that SGD can effectively upregulate the expression of PI3K and AKT proteins.
Conclusion: This is the first in-depth study on the mechanism of SGD's treatment effect in AA using network pharmacology, and preliminary animal experiments verified that it is closely related to the PI3K/AKT signaling pathway. This finding may provide a new basis for SGD's clinical application in AA.
Copyright © 2022 Shuying Lv et al.
Conflict of interest statement
The authors report no conflicts of interest.
Figures








Similar articles
-
Network pharmacology and experimental verification of the potential mechanism of Er-Xian decoction in aplastic anemia.Sci Rep. 2023 Oct 13;13(1):17385. doi: 10.1038/s41598-023-44672-9. Sci Rep. 2023. PMID: 37833363 Free PMC article.
-
[Mechanism of Danggui Sini Decoction in treatment of primary dysmenorrhea based on network pharmacology and molecular docking].Zhongguo Zhong Yao Za Zhi. 2021 Feb;46(4):855-864. doi: 10.19540/j.cnki.cjcmm.20201104.401. Zhongguo Zhong Yao Za Zhi. 2021. PMID: 33645090 Chinese.
-
Network Pharmacology Combined with Molecular Docking and Experimental Verification Reveals the Bioactive Components and Potential Targets of Danlong Dingchuan Decoction against Asthma.Evid Based Complement Alternat Med. 2022 Feb 10;2022:7895271. doi: 10.1155/2022/7895271. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35186104 Free PMC article.
-
Exploration of the mechanism of Zisheng Shenqi decoction against gout arthritis using network pharmacology.Comput Biol Chem. 2021 Feb;90:107358. doi: 10.1016/j.compbiolchem.2020.107358. Epub 2020 Aug 8. Comput Biol Chem. 2021. PMID: 33243703 Review.
-
Network pharmacology prediction and molecular docking-based strategy to explore the potential mechanism of Huanglian Jiedu Decoction against sepsis.Comput Biol Med. 2022 May;144:105389. doi: 10.1016/j.compbiomed.2022.105389. Epub 2022 Mar 9. Comput Biol Med. 2022. PMID: 35303581 Review.
Cited by
-
Chemical Constituents of Halophyte Suaeda glauca and Their Therapeutic Potential for Hair Loss.Molecules. 2024 Jan 6;29(2):298. doi: 10.3390/molecules29020298. Molecules. 2024. PMID: 38257211 Free PMC article.
-
Treatment of hypotrichosis simplex of the scalp with the combination of botanic extracts and minoxidil: a case report.Front Genet. 2025 Jan 20;15:1491870. doi: 10.3389/fgene.2024.1491870. eCollection 2024. Front Genet. 2025. PMID: 39902296 Free PMC article.
References
-
- Wang T. L., Shen W. Y., Zhou C., et al. A survey on the prevalence of alopecia areata in six Chinese cities. Chinese Journal of Dermatology . 2009;10:668–670.
-
- Chinese Medical Association D., Branch V., Hair Group The Chinese Guidelines for the treatment of alopecia areata (2019) The American Journal of Clinical Dermatology . 2020;49(2):69–72.
-
- Qu Y. Z., Ma S. J., Zhu G. W., et al. Historical evolution and modern research on Shaoyao gancaotang. Chinese Journal of Experimental Traditional Medical Formulae . 2020;26(6):216–225.
-
- Yang D., Zheng J., Zhang Y., Jin Y., Gan C., Bai Y. Total glucosides of paeony capsule plus compound glycyrrhizin tablets for the treatment of severe alopecia areata in children: a randomized controlled trial. Evidence-Based Complementary and Alternative Medicine . 2013;2013 doi: 10.1155/2013/378219.378219 - DOI - PMC - PubMed
-
- Qin C. F. Clinical and Immune Mechanism Study of Shaoyao Gancao Granule in the Treatment of Severe Alopecia Areata . Chaoyang, China: Beijing University of Traditional Chinese Medicine; 2020.
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous